Cargando…

ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer

BACKGROUND: Lung cancer is the leading cause of cancer-related deaths with 1.8 million new cases each year and poor 5-year prognosis. Promoter hypermethylation of tumour suppressors leads to their inactivation and thereby can promote cancer development and progression. RESULTS: In this study, we ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richter, Antje M., Kiehl, Steffen, Köger, Nicole, Breuer, Janina, Stiewe, Thorsten, Dammann, Reinhard H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457737/ https://www.ncbi.nlm.nih.gov/pubmed/28588743 http://dx.doi.org/10.1186/s13148-017-0360-4

Ejemplares similares

Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function
por: Deutschmeyer, Verena, et al.
Publicado: (2019)

Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis
por: Küster, Miriam M., et al.
Publicado: (2020)

Muerte al zar/
por: Williams, Andrew 1970-
Publicado: (2011)

The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth
por: Jiménez, Adriana P., et al.
Publicado: (2017)

El loco del zar /
por: Kross, Jaan
Publicado: (1992)

Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer
por: Richter, Antje M., et al.
Publicado: (2016)

Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
por: Schagdarsurengin, Undraga, et al.
Publicado: (2010)

LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer
por: Liu, W-b, et al.
Publicado: (2013)

ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth
por: Kiehl, Steffen, et al.
Publicado: (2014)

Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer
por: Kiehl, Steffen, et al.
Publicado: (2017)

ZAR1: Guardian of plant kinases
por: Breit-McNally, Clare, et al.
Publicado: (2022)

ZAR1 and ZAR2 are required for oocyte meiotic maturation by regulating the maternal transcriptome and mRNA translational activation
por: Rong, Yan, et al.
Publicado: (2019)

Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update
por: Llinàs-Arias, Pere, et al.
Publicado: (2017)

RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice
por: Richter, Antje M., et al.
Publicado: (2020)

The SARAH Domain of RASSF1A and Its Tumor Suppressor Function
por: Dittfeld, Claudia, et al.
Publicado: (2012)

Tracing the evolution of the ZAR1 resistosome back to the Jurassic era
por: Chan, Ching
Publicado: (2023)

Cinco mujeres contra el Zar : Vera Figner, Vera Zasulich, Praskovia Ivanovskaya, Olga Liubatovich, Elizaveta Kovalskaya
Publicado: (1980)

The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
por: Hesson, Luke B, et al.
Publicado: (2009)

RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer
por: Richter, Antje M., et al.
Publicado: (2019)

Identification of Endoglin as an epigenetically regulated tumour-suppressor gene in lung cancer
por: O'Leary, K, et al.
Publicado: (2015)

Is DNA methylation of tumour suppressor genes epigenetic?
por: Struhl, Kevin
Publicado: (2014)

Maize ARGOS1 (ZAR1) transgenic alleles increase hybrid maize yield
por: Guo, Mei, et al.
Publicado: (2014)

Immunodiversity of the Arabidopsis ZAR1 NLR Is Conveyed by Receptor-Like Cytoplasmic Kinase Sensors
por: Martel, Alexandre, et al.
Publicado: (2020)

The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer
por: Richter, A M, et al.
Publicado: (2012)

Impact of Natural Compounds on DNA Methylation Levels of the Tumor Suppressor Gene RASSF1A in Cancer
por: Dammann, Reinhard H., et al.
Publicado: (2017)

Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase
por: Serrano, Isabel, et al.
Publicado: (2013)

Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer
por: Dopeso, Higinio, et al.
Publicado: (2018)

The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanisms
por: Haag, Tanja, et al.
Publicado: (2016)

The apoptosis associated tyrosine kinase gene is frequently hypermethylated in human cancer and is regulated by epigenetic mechanisms
por: Haag, Tanja, et al.
Publicado: (2014)

Aberrant Methylation of Gene Associated CpG Sites Occurs in Borderline Personality Disorder
por: Teschler, Stefanie, et al.
Publicado: (2013)

Epigenetic and genetic inactivation of tumor suppressor miR ‐135a in non‐small‐cell lung cancer
por: Choi, Jin Eun, et al.
Publicado: (2023)

The Arabidopsis Receptor Kinase ZAR1 Is Required for Zygote Asymmetric Division and Its Daughter Cell Fate
por: Yu, Tian-Ying, et al.
Publicado: (2016)

Epigenetics provides a new generation of oncogenes and tumour-suppressor genes
por: Esteller, M
Publicado: (2006)

DNA hypermethylation of zygote arrest 1 (ZAR1) in hepatitis C virus positive related hepatocellular carcinoma
por: Takagi, Keiko, et al.
Publicado: (2013)

Zār Spirit Possession in Iran and African Countries: Group Distress, Culture-Bound Syndrome or Cultural Concept of Distress?
por: Mianji, Fahimeh, et al.
Publicado: (2015)

The Zygotic Division Regulator ZAR1 Plays a Negative Role in Defense Against Botrytis cinerea in Arabidopsis
por: Chen, Lijuan, et al.
Publicado: (2021)

SMG1 Acts as a Novel Potential Tumor Suppressor with Epigenetic Inactivation in Acute Myeloid Leukemia
por: Du, Yahui, et al.
Publicado: (2014)

OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation
por: Cui, Yan, et al.
Publicado: (2008)

RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma
por: Wang, Fei, et al.
Publicado: (2015)

TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer
por: Liu, Wen-bin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_up770khs4emhnckc6ea8fclalp